skip to main content

News Archive

Date: 06/03/2017
Nearly three dozen U-M Cancer Center faculty and trainees will be presenting oral abstracts or posters, leading discussion of new research or chairing sessions during the ASCO annual meeting, June 2-6.
Date: 06/03/2017
A new analysis finds that nearly three-quarters of 500 patients with advanced cancer could be referred to a potential targeted treatment based on the results of a comprehensive analysis of their tumor’s genetic landscape.
Date: 06/02/2017
Nearly three dozen U-M Cancer Center faculty and trainees will be presenting oral abstracts or posters, leading discussion of new research or chairing sessions during the ASCO annual meeting, June 2-6.
Date: 06/01/2017
Dozens of U-M Cancer Center faculty are presenting oral abstracts and posters during the annual ASCO conference.
Date: 06/01/2017
Daniel Hayes, M.D., Clinical Director of the Breast Oncology Program in the University of Michigan Comprehensive Cancer Center, discusses the results of trials involving the use of anti-estrogen therapy for more than five years for breast cancer patients.
Date: 05/26/2017
All cancer survivors, families, friends and health care providers are invited to The University of Michigan Comprehensive Caner Center’s Survivors Day Celebration on June 4.
Date: 05/23/2017
Triple-negative is the most aggressive kind of breast cancer. Triple negative tumors are negative for estrogen receptor, progesterone receptor and the HER2 protein. Because treatments that target these proteins would not work in triple negative breast cancer, the main treatment for it is chemotherapy.
Date: 05/22/2017
In a randomized clinical trial conducted by researchers at University of Southampton, biliary cancer patients treated with capecitabine as adjuvant therapy lived, on average, more than a year longer than those who were only observed, according to a post in HemOnc Today.
Date: 05/22/2017
The Daily Mail reports that a new study, released in advance of the upcoming American Society of Clinical Oncology annual meeting, links the regular consumption of tree nuts such as almonds, cashews and Brazil nuts, to better outcomes for colon cancer patients.
Date: 05/16/2017
The number of people diagnosed with thyroid cancer is increasing -- one of the few cancers for which this is still the case. But a subset of these patients may be getting overdiagnosed with cancer.

Pages